1-4 of 4
Alissa R. Kahn
Close
Sort by
Journal Articles

COVID-19 Infection in Children with Down Syndrome and Hematologic Malignancies

Blake Foxworthy, Elizabeth C Davis, Ana C. Xavier, Julienne Brackett, David Dickens, Alissa R. Kahn, Isaac Martinez, Archana Sharma, Carla Schwalm, Jessica M. Foley, Jennifer J. Wilkes, Smita Bhatia, Jennifer M Levine, Emily Johnston, Julie A. Wolfson
Journal: Blood
Blood (2022) 140 (Supplement 1): 8030–8031.
https://doi.org/10.1182/blood-2022-158833
Published: 2022
Journal Articles

Identification of Small Molecules Selectively Targeting Leukemic Stem Cells within Their Stromal Niche

Alissa R. Kahn, MD, Kimberly A. Hartwell, PhD, Peter G. Miller, PhD, Benjamin L. Ebert, MD, PhD, Todd R. Golub, MD, Malcolm A.S. AS Moore
Journal: Blood
Blood (2012) 120 (21): 413.
https://doi.org/10.1182/blood.V120.21.413.413
Published: 2012
Journal Articles

Niche-Based Screening Reveals Leukemia Stem Cell Specific Therapeutics

Kimberly A. Hartwell, PhD, Peter G. Miller, PhD, Alison L. Stewart, PhD, Alissa R. Kahn, MD, David J. Logan, PhD, Joseph Negri, Mildred Duvet, Shrikanta Chattopadhyay, MD, Sebastian Shterental, Lisa P Chu, Jae Hung Shieh, PhD, Marcus Jaeraas, MD, Vladimir Dancik, PhD, Rajiv Narayan, PhD, Christina Huang, J Erika Haydu, Siddhartha Mukherjee, MD, PhD, Alykhan F Shamji, PhD, Nicola J Tolliday, PhD, Anne E. Carpenter, PhD, Stuart L. Schreiber, PhD, Andrew M. Stern, PhD, Malcolm AS Moore, D Phil, David T. Scadden, MD, Benjamin L. Ebert, MD, D.Phil, Todd R. Golub, MD
Journal: Blood
Blood (2011) 118 (21): 760.
https://doi.org/10.1182/blood.V118.21.760.760
Published: 2011
Journal Articles

Selective Targeting of Leukemic Over Normal Stem Cells by the Serotonin Receptor Antagonist SB-216641

Alissa R. Kahn, MD, Kimberly A. Hartwell, PhD, Peter G. Miller, PhD, Benjamin L. Ebert, MD, D.Phil, Todd R. Golub, MD, Malcolm A.S. Moore, D.Phil
Journal: Blood
Blood (2011) 118 (21): 1884.
https://doi.org/10.1182/blood.V118.21.1884.1884
Published: 2011